Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1638536 | 0.86 | CXCR4 (0.39) | CXCR4DRD2 | |
| SCHEMBL1638165 | 0.80 | CXCR4 (0.41) | CXCR4DRD2 | |
| SCHEMBL1638301 | 0.79 | CXCR4 (0.37) | CXCR4 | |
| SCHEMBL1637499 | 0.79 | CXCR4 (0.54) | CXCR4DRD2 | |
| SCHEMBL1638209 | 0.75 | CNR2 (0.42) | — | |
| SCHEMBL1636497 | 0.73 | SSTR4 (0.35) | — | |
| SCHEMBL19334046 | 0.73 | FPR2 (0.37) | — | |
| SCHEMBL1637308 | 0.72 | CXCR4 (0.47) | CXCR4DRD2 | |
| SCHEMBL1638305 | 0.71 | AAK1 (0.33) | — | |
| SCHEMBL1638648 | 0.70 | KDM4E (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1724263-B1 | BASIC AMINE COMPOUND AND USE THEREOF | KUREHA CORP (JP) | 2014-03-05 | — | — | EP | disclosed |
| US-20110172212-A1 | AMINE-BASED COMPOUND AND USE THEREOF | KUREHA CORPORATION (JP) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172212-A1 | AMINE-BASED COMPOUND AND USE THEREOF | NR0B2, NR5A2, NR1D2 | CXCR4 86/4885DRD2 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.